EV/EBITDA
-0.48
-0.01-2.13%
Fri, 29 Nov 2024 21:14:01 GMT
Summary:
Prelude Therapeutics Incorporated EV/EBITDA is currently -0.48, with a fall of -0.01 (-2.13%) during the most recent trading day. Over the past year, it has increased by +0.85 (+63.91%). PRLD EV/EBITDA is now -17.07% below its all-time high of -0.41.PRLD EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRLD EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -2.1% |
| 1 m1 month | +22.6% |
| 3 m3 months | +76.8% |
| 6 m6 months | +62.8% |
| ytdytd | +72.1% |
| 1 y1 year | +63.9% |
| 5 y5 years | - |
PRLD EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -0.41 | -17.1% | -0.62 | +22.6% |
| 3 m | 3 months | -0.41 | -17.1% | -2.07 | +76.8% |
| 6 m | 6 months | -0.41 | -17.1% | -2.43 | +80.3% |
| 1 y | 1 year | -0.41 | -17.1% | -2.43 | +80.3% |
| 3 y | 3 years | -0.41 | -17.1% | -6.41 | +92.5% |
| 5 y | 5 years | -0.41 | -17.1% | -74.73 | +99.4% |
| alltime | all time | -0.41 | -17.1% | -74.73 | +99.4% |
Prelude Therapeutics Incorporated EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -0.48(-72.1%) |
| 2023 | -1.72(-18.9%) |
| Date | Value |
|---|---|
| 2022 | -2.12(-57.5%) |
| 2021 | -4.99(-90.0%) |
| 2020 | -49.96 |
FAQ
- What is Prelude Therapeutics Incorporated EV/EBITDA?
- What is the all time high EV/EBITDA for Prelude Therapeutics Incorporated?
- What is PRLD EV/EBITDA year-to-date change?
- What is Prelude Therapeutics Incorporated EV/EBITDA year-on-year change?
What is Prelude Therapeutics Incorporated EV/EBITDA?
The current EV/EBITDA of PRLD is -0.48
What is the all time high EV/EBITDA for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high EV/EBITDA is -0.41
What is PRLD EV/EBITDA year-to-date change?
Prelude Therapeutics Incorporated EV/EBITDA has changed by +1.24 (+72.09%) since the beginning of the year
What is Prelude Therapeutics Incorporated EV/EBITDA year-on-year change?
Over the past year, PRLD EV/EBITDA has changed by +0.85 (+63.91%)